Association of rs1544410 and rs7975232 Polymorphisms and Serum Vitamin D Levels with Psoriasis Susceptibility and Severity: A Case–Control Study in Egyptian Patients

References

• Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–886. doi:10.2310/JIM.0b013e31821b8755
   PubMed Web of Science ®Google Scholar
• Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol. 2016;45(6):439–447. doi:10.3109/03009742.2016.1151072
   PubMed Web of Science ®Google Scholar
• Zhang Y, Leung DY, Richers BN, et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase- 1. J Immunol. 2012;188(5):2127–2135. doi:10.4049/jimmunol.1102412
   PubMed Web of Science ®Google Scholar
• Joshi S, Pantalena L-C, Liu XK, et al. 1, 25-Dihydroxyvitamin D3 ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31:3653–3669. doi:10.1128/MCB.05020-11
   PubMed Web of Science ®Google Scholar
• Mattner F, Smiroldo S, Galbiati F, et al. Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1, 25-dihydroxyvitamin D3. Eur J Immunol. 2000;30(2):498–508. doi:10.1002/1521-4141(200002)30:2<498::AID-IMMU498>3.0.CO;2-Q
   PubMed Web of Science ®Google Scholar
• Sun L, Arbesman J, Piliang M. Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors. Arch Dermatol Res. 2021;313(1):1. doi:10.1007/s00403-020-02094-x
   PubMed Web of Science ®Google Scholar
• Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70(3):512–516. PMID: 24388724. doi:10.1016/j.jaad.2013.11.013
   PubMed Web of Science ®Google Scholar
• Lee YH, Song GG. Association between circulating 25-hydroxyvitamin D levels and psoriasis, and correlation with disease severity: a meta-analysis. Clin Exp Dermatol. 2018;43(5):529–535. PMID: 29341195. doi:10.1111/ced.13381
   PubMed Web of Science ®Google Scholar
• Pitukweerakul S, Thavaraputta S, Prachuapthunyachart S, Karnchanasorn R. Hypovitaminosis D is associated with psoriasis: a systematic review and meta-analysis. Kans J Med. 2019;12(4):103–108. PMID: 31803350; PMCID: PMC6884011. doi:10.17161/kjm.v12i4.13255
   PubMedGoogle Scholar
• Lee YH. Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: an updated meta-analysis. Clin Exp Dermatol. 2019;44(5):498–505. PMID: 30474246. doi:10.1111/ced.13823
   PubMed Web of Science ®Google Scholar
• Liu J, Wang W, Liu K, et al. Vitamin D receptor gene polymorphisms are associated with psoriasis susceptibility and the clinical response to calcipotriol in psoriatic patients. Exp Dermatol. 2020;29(12):1186–1190. doi:10.1111/exd.14202
   PubMed Web of Science ®Google Scholar
• Mattei PL, Corey KC, Kimball AB. Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological burden in patients treated with biological therapies. J Eur Acad Dermatol Venereol. 2014;28(3):333–337. PMID: 23425140. doi:10.1111/jdv.12106
   PubMed Web of Science ®Google Scholar
• Martinez-Millana A, Hulst JM, Boon M, et al. Optimisation of children z-score calculation based on new statistical techniques. PLoS One. 2018;13(12):e0208362. doi:10.1371/journal.pone.0208362
   PubMed Web of Science ®Google Scholar
• Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170–173. PMID: 34001566; PMCID: PMC8140694. doi:10.7861/clinmed.2021-0257
   PubMed Web of Science ®Google Scholar
• Nanda H, Ponnusamy N, Odumpatta R, Jeyakanthan J, Mohanapriya A. Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing. 3 Biotech. 2020;10(2):43. PMID: 31988837; PMCID: PMC6954159. doi:10.1007/s13205-019-2038-4
   PubMedGoogle Scholar
• Nair RP, Stuart PE, Nistor I, et al. Sequence and haplotype analysis supports HLA-C as the psoriasis susceptibility 1 gene. Am J Hum Genet. 2006;78(5):827–851. doi:10.1086/503821
   PubMed Web of Science ®Google Scholar
• Zhang XJ, Huang W, Yang S, et al. Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21. Nat Genet. 2009;41(2):205–210. doi:10.1038/ng.310
   PubMed Web of Science ®Google Scholar
• Pillai S, Bikle DD, Elias PM. 1,25-Dihydroxyvitamin D production and receptor binding in human keratinocytes varies with differentiation. J Biol Chem. 1988;263(11):5390–5395. doi:10.1016/S0021-9258(18)60729-X
   PubMed Web of Science ®Google Scholar
• De Haes P, Garmyn M, Carmeliet G, et al. Molecular pathways involved in the anti-apoptotic effect of 1,25-dihydroxyvitamin D3 in primary human keratinocytes. J Cell Biochem. 2004;93(5):951–967. doi:10.1002/jcb.20227
   PubMed Web of Science ®Google Scholar
• Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One. 2015;10(11):e0141770. PMID: 26528817; PMCID: PMC4631349. doi:10.1371/journal.pone.0141770
   PubMed Web of Science ®Google Scholar
• De Haes P, Garmyn M, Degreef H, Vantieghem K, Bouillon R, Segaert S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem. 2003;89(4):663–673. doi:10.1002/jcb.10540
   PubMed Web of Science ®Google Scholar
• Fisher SA, Rahimzadeh M, Brierley C, et al. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PLoS One. 2019;14(9):e0222313. PMID: 31550254; PMCID: PMC6759203. doi:10.1371/journal.pone.0222313
   PubMed Web of Science ®Google Scholar
• Wang -T-T, Nestel FP, Bourdeau V, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173:2909–2912. doi:10.4049/jimmunol.173.5.2909
   PubMed Web of Science ®Google Scholar
• Weber G, Heilborn JD, Chamorro Jimenez CI, Hammarsjö A, Törmä H, Ståhle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol. 2005;124(5):1080–1082. doi:10.1111/j.0022-202X.2005.23687.x
   PubMed Web of Science ®Google Scholar
• Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol. 2016;63(1):17–29. PMID: 26824295. doi:10.18388/abp.2015_1104
   PubMed Web of Science ®Google Scholar
• Ahmed Mohamed A, Salah Ahmed EM, Farag YMK, Bedair NI, Nassar NA, Ghanem AIM. Dose-response association between vitamin D deficiency and atopic dermatitis in children, and effect modification by gender: a case-control study. J Dermatolog Treat. 2021;32(2):174–179. PMID: 31296076. doi:10.1080/09546634.2019.1643447
   PubMed Web of Science ®Google Scholar
• Karagün E, Ergin C, Baysak S, Erden G, Aktaş H, Ekiz Ö. The role of serum vitamin D levels in vitiligo. Postepy Dermatol Alergol. 2016;33(4):300. doi:10.5114/pdia.2016.59507
   PubMed Web of Science ®Google Scholar
• Zuchi MF, Pde OA, Tanaka AA, Schmitt JV, Martins LE. Serum levels of 25-hydroxy vitamin D in psoriatic patients. An Bras Derm. 2015;90(3):430–432. doi:10.1590/abd1806-4841.20153524
   PubMed Web of Science ®Google Scholar
• Wilson PB. Serum 25-hydroxyvitamin D status in individuals with psoriasis in the general population. Endocrine. 2013;44(2):537–539. doi:10.1007/s12020-013-9989-8
   PubMed Web of Science ®Google Scholar
• Solak B, Dikicier BS, Celik HD, Erdem T. Bone mineral density, 25-OH vitamin D and inflammation in patients with psoriasis. Photodermatol Photoimmunol Photomed. 2016;32(3):153–160. doi:10.1111/phpp.12239
   PubMed Web of Science ®Google Scholar
• Maleki M, Nahidi Y, Azizahari S, Meibodi NT, Hadianfar A. Serum 25-OH vitamin D level in psoriatic patients and comparison with control subjects. J Cutan Med Surg. 2016;20(3):207–210. doi:10.1177/1203475415622207
   PubMed Web of Science ®Google Scholar
• Merola JF, Han J, Li T, Qureshi AA. No association between vitamin D intake and incident psoriasis among US women. Arch Dermatol Res. 2014;306(3):305–307. doi:10.1007/s00403-013-1426-6
   PubMed Web of Science ®Google Scholar
• Morimoto S, Yoshikawa K, Fukuo K, et al. Inverse relation between severity of psoriasis and serum 1,25-dihydroxy-vitamin D level. J Dermatol Sci. 1990;1(4):277–282. doi:10.1016/0923-1811(90)90120-3
   PubMedGoogle Scholar
• Atwa MA, Balata MG, Hussein AM, Abdelrahman NI, Elminshawy HH. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med J. 2013;34(8):806–813.
   PubMed Web of Science ®Google Scholar
• Mattozzi C, Paolino G, Salvi M, et al. Peripheral blood regulatory T cell measurements correlate with serum vitamin D level in patients with psoriasis. Age. 2016;56:23–85.
   Google Scholar
• Bergler-Czop B, Brzezińska-Wcisło L. Serum vitamin D level - the effect on the clinical course of psoriasis. Postepy Dermatol Alergol. 2016;6(6):445–449. PMID: 28035222; PMCID: PMC5183783. doi:10.5114/ada.2016.63883
   Web of Science ®Google Scholar
• Zaher HA, El-Komy MH, Hegazy RA, El Khashab HA, Ahmed HH. Assessment of interleukin-17 and vitamin D serum levels in psoriatic patients. J Am Acad Dermatol. 2013;69(5):840–842. doi:10.1016/j.jaad.2013.07.026
   PubMed Web of Science ®Google Scholar
• Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Acad Dermatol. 2012;67(5):931–938. PMID: 22387034. doi:10.1016/j.jaad.2012.01.040
   PubMed Web of Science ®Google Scholar
• Ricceri F, Pescitelli L, Tripo L, Prignano F. Deficiency of serum concentration of 25-hydroxyvitamin D correlates with severity of disease in chronic plaque psoriasis. J Am Acad Dermatol. 2013;68(3):511–512. doi:10.1016/j.jaad.2012.10.051
   PubMed Web of Science ®Google Scholar
• Kincse G, Bhattoa PH, Heredi E, et al. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J Dermatol. 2015;42:679–684. doi:10.1111/1346-8138.12876
   PubMed Web of Science ®Google Scholar
• Mattozzi C, Paolino G, Richetta AG, Calvieri S. Psoriasis, vitamin D and the importance of the cutaneous barrier’s integrity: an update. J Dermatol. 2016;43(5):507–514. doi:10.1111/1346-8138
   PubMed Web of Science ®Google Scholar
• Visconti B, Paolino G, Carotti S, et al. Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin. J Eur Acad Dermatol Venereol. 2015;29(10):2038–2042. doi:10.1111/jdv.12736
   PubMed Web of Science ®Google Scholar
• Chandra R, Roesyanto‐Mahadi ID, Yosi A. Pilot study: immunohistochemistry expressions of vitamin D receptor associated with severity of disease in psoriasis patients. Int J Dermatol. 2020;59(9):1092–1097.
   PubMed Web of Science ®Google Scholar
• Kaya TI, Erdal ME, Tursen U, et al. Association between vitamin D receptor gene polymorphism and psoriasis among the Turkish population. Arch Dermatol Res. 2002;294(6):286–289. doi:10.1007/s00403-002-0326-y
   PubMed Web of Science ®Google Scholar
• Dayangac-Erden D, Karaduman A, Erdem-Yurter H. Polymorphisms of vitamin D receptor gene in Turkish familial psoriasis patients. Arch Dermatol Res. 2007;299(10):487–491. doi:10.1007/s00403-007-0782-5
   PubMed Web of Science ®Google Scholar
• Park BS, Park JS, Lee DY, et al. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol. 1999;112(1):113–116. doi:10.1046/j.1523-1747.1999.00482.x
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen X, Li J, et al. VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients. J Dermatol Sci. 2015;79(3):305–307. doi:10.1016/j.jdermsci.2015.06.014
   PubMed Web of Science ®Google Scholar
• Zuel-Fakkar NM, Kamel MM, Asaad MK, et al. A study ofApaI and TaqI genotypes of the vitamin D receptor inEgyptian patients with psoriasis. Clin Exp Dermatol. 2011;36(4):355–359. doi:10.1111/j.1365-2230.2010.03970.x
   PubMed Web of Science ®Google Scholar
• Richetta AG, Silvestri V, Giancristoforo S, et al. A-1012G promoter polymorphism of vitamin D receptor gene is associated with psoriasis risk and lower allele-specific expression. DNA Cell Biol. 2014;33(2):102–109. doi:10.1089/dna.2013.2217
   PubMed Web of Science ®Google Scholar
• Zhou X, Xu LD, Li YZ. The association of polymorphisms of the vitamin D receptor gene with psoriasis in the Hanpopulation of northeastern China. J Dermatol Sci. 2014;73(1):63–66. doi:10.1016/j.jdermsci.2013.08.014
   PubMed Web of Science ®Google Scholar
• Rucevic I, Stefanic M, Tokic S, et al. Lack of association of vitamin D receptor gene 30-haplotypes with psoriasis in Croatian patients. J Dermatol. 2012;39(1):58–62. doi:10.1111/j.1346-8138.2011.01296.x
   PubMed Web of Science ®Google Scholar
• Okita H, Ohtsuka T, Yamakage A, Yamazaki S. Polymorphism of the vitamin D3 receptor in patients with psoriasis. Arch Dermatol Res. 2002;294(4):159–162. doi:10.1007/s00403-002-0314-2
   PubMed Web of Science ®Google Scholar
• Wohlers I, Künstner A, Munz M, et al. An integrated personal and population-based Egyptian genome reference. Nat Commun. 2020;11(1):4719. PMID: 32948767; PMCID: PMC7501257. doi:10.1038/s41467-020-17964-1
   PubMed Web of Science ®Google Scholar
• Ruggiero M, Gulisano M, Peruzzi B, et al. Vitamin D receptor gene polymorphism is not associated with psoriasis in Italian Caucasian population. J Dermatol Sci. 2004;35(1):68–70. doi:10.1016/j.jdermsci.2004.02.007
   PubMed Web of Science ®Google Scholar
• Liu JL, Zeng HM, Lin MG, et al. Association of vitamin D receptor polymorphisms with susceptibility to psoriasis vulgaris and clinical response to calcipotriol in patients with psoriasis vulgaris. Chin J Dermatol. 2017;50(12):889–893.
   Google Scholar
• Saeki H, Asano N, Tsunemi Y, et al. Polymorphisms of vitamin D receptor gene in Japanese patients with psoriasis vulgaris. J Dermatol Sci. 2002;30(2):167–171. doi:10.1016/S0923-1811(02)00073-7
   PubMed Web of Science ®Google Scholar
• Mee JB, Cork MJ. Vitamin D receptor polymorphism and calcipotriol response in patients with psoriasis. J Invest Dermatol. 1998;110(3):301–302. doi:10.1046/j.1523-1747.1998.00128.x
   PubMed Web of Science ®Google Scholar
• Lee DY, Park BS, Choi KH, et al. Vitamin D receptor genotypes are not associated with clinical response to calcipotriol in Korean psoriasis patients. Arch Dermatol Res. 2002;294(1–2):1–5. doi:10.1007/s00403-002-0293-3
   PubMed Web of Science ®Google Scholar
• Zhu HQ, Xie KC, Chen LD, et al. The association between vitamin D receptor polymorphism and psoriasis. Chin J Dermatol. 2002;35:386–388.
   Google Scholar
• Stefanic M, Rucevic I, Barisic‐Drusko V. Meta‐analysis of vitamin D receptor polymorphisms and psoriasis risk. Int J Dermatol. 2013;52(6):705–710. doi:10.1111/j.1365-4632.2012.5813.x
   PubMed Web of Science ®Google Scholar